ArticleKidney international reports2023
Safety and Efficacy of Vedolizumab in Kidney Transplant Recipients With Crohn's Disease.
Marco Busutti et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it